BNP Paribas Financial Markets
OACC

BNP Paribas Financial Markets’s Oaktree Acquisition Corp III Life Sciences OACC Stock Holding History

BNP Paribas Financial Markets’s Portfolio OACC Stock Details OACC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$862K Buy
+81,520
New +$868K ﹤0.01% 3242

Other funds holding OACC

AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
DAM
Decagon Asset Management London, United Kingdom $386M AUM 45.42% 1-Year Est. Return
FBCM
Fort Baker Capital Management Larkspur, California $1.27B AUM 25.46% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BGIM
Boussard & Gavaudan Investment Management London, United Kingdom $1.06B AUM 4.58% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

BNP Paribas Financial Markets's OACC Position: Q1 2026 in Review

BNP Paribas Financial Markets opened a new position in Oaktree Acquisition Corp III Life Sciences (OACC) in Q1 2026: 81,520 shares worth $862K. The stake represents ﹤0.01% of the portfolio and ranks #3242 among its holdings.

51 funds tracked by Wall St. Rank hold OACC as of Q1 2026.

  • BNP Paribas Financial Markets held 81,520 shares of Oaktree Acquisition Corp III Life Sciences worth $862K as of Q1 2026.
  • Oaktree Acquisition Corp III Life Sciences was a new BNP Paribas Financial Markets position in Q1 2026.
  • Oaktree Acquisition Corp III Life Sciences made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #3242 holding.
  • 51 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.